Agilent Technologies acquires Cartagenia

Agilent Technologies acquired Cartagenia for approximately €60 million, a transaction completed in May 2015, structured as all cash.

Cartagenia operates in Diagnostics and Genomics, is based in Leuven, Belgium. Cartagenia provides software and services for clinical genetics and molecular pathology laboratories. Its Bench platform lets labs assess and report variants from next-generation sequencing and microarray data, putting genomic results in clinical context for lab directors and clinicians.

Cartagenia added clinical-grade variant interpretation and reporting informatics to Agilent's genomics workflow, letting customers turn the data Agilent's platforms generate into clinical reports.

Advisory firms were not disclosed for this transaction.

You're subscribed.

Thanks for signing up.